Alliance Member-Only Meeting with James Lucier, Capital Alpha Partners 

We held an off-the-record conversation with James Lucier of Capital Alpha Partners about the implications of the debt deal for research, public health, and public-private R&D partnerships. What is the outlook for funding for NIH and other research and public health agencies? What does the deal mean for pandemic preparedness? What can advocates do to help shape the answers to those questions? Does the deal affect other legislative efforts, like reauthorization of PAHPA.